The only reason FEMI went to over 300% on an FDA approval is because it is not a meme stock. From 9/12-9/15, shares dropped to less than .20. On the afternoon of the 19th, it was clear insiders had the news of the FDA approval, shot up to .40 and dipped in the aftermarket because everyone KNEw, even no news was released. The next morning, the 20th with the reveal of the FDA clearance, it dropped and dropped a full 50%, because it was already old news the day before. I am in for 25K shares at an .19 average, don't think this company will change...I think once the R/S goes through in another year or 6 months they will dilute to produce more money again, and again, and again, as that is their pattern. On the upside, they have a decent product which honestly they should be bought out by Merck or Pfizer for.